Fluticasone-salmeterol 115-21 12GM
Ended Awarded
- Contract number
- SPE2DB26FDR34
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,417
Award facts
- Contract value 100% obligated
- $12,417.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,417.47 to AmerisourceBergen Drug Corp for Fluticasone-Salmeterol 115-21 12GM pharmaceutical products, with an ultimate completion date of October 17, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen Drug Corp's role as a critical pharmaceutical supplier to federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The DLA intends to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp among the anticipated awardees serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FDR34?
SPE2DB26FDR34 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FDR34 worth?
The government has obligated $12,417 on SPE2DB26FDR34.
Is contract SPE2DB26FDR34 an order under another contract?
Yes. SPE2DB26FDR34 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDR34 competed?
The extent of competition for SPE2DB26FDR34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award